A team at Weill Cornell Medicine has mapped the location and spatial features of blood-forming cells within human bone marrow, confirming hypotheses about the anatomy of this tissue and providing a powerful new means to study diseases that affect bone marrow.
Cornell researchers are helping to improve and expand a program that makes fresh, locally grown fruits and vegetable more affordable for New York state families with low incomes.
In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
A consortium of 13 research institutions, including Cornell, received a $1.5 million grant from The Andrew W. Mellon Foundation to launch the Ivy+ Mellon Leadership Fellows program this fall.
Osei Boateng ’18, MHA ’20, founder of OKB Hope Foundation, a nonprofit dedicated to transforming health care delivery in Africa, is the latest guest on the Startup Cornell podcast.
A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in Type 2 diabetes, according to a new study by Weill Cornell Medicine investigators.
After service in the military, Chris Brunkhorst and Caleb Jones sought new outlets to channel their discipline and their commitment to helping others – and they both found it in neuroscience.
Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with Type 2 diabetes – a condition that affects more than 500 million people worldwide.
